[NLSP] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[NLSP] NLS Pharmaceutics AG
Announcement Date
24-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -59.53%
YoY- -350.77%
Quarter Report
NLSP's Result
NLSP's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -7,613 -7,855 -8,641 -7,343 -4,603 -1,629 -1,232 83.50%
Tax -0 -0 -0 0 -0 0 -1 -
NP -7,613 -7,855 -8,641 -7,343 -4,603 -1,629 -1,232 83.50%
Tax Rate - - - - - - - -
Total Cost 7,613 7,855 8,641 7,343 4,603 1,629 1,232 83.50%
Ratio Analysis
30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 CAGR
EPS -0.20 -0.29 -0.54 -0.50 -0.42 -0.34 -0.11 22.05%
EPS Diluted -0.20 -0.29 -0.54 -0.50 -0.42 -0.34 -0.11 22.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.